Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
memo - Magazine of European Medical Oncology
Published in: memo - Magazine of European Medical Oncology 4/2017

Open Access 01-12-2017 | short review

ASCO 2017—highlights of gynecological cancer

Authors: Bianca Radl, Brigitte Mlineritsch

Published in: memo - Magazine of European Medical Oncology | Issue 4/2017

Login to get access

Summary

At this year’s ASCO annual meeting several important studies in the field of gynecological cancer were presented. Here we report a personal selection of the most interesting and clinically relevant data.
Literature
1.
Harter P, et al. J Clin Oncol. 2017;35(suppl):abstr 5500.
2.
du Bois A, et al. J Clin Oncol. 2017;35(suppl):abstr 5501.
3.
Van Driel WJ. J Clin Oncol. 2017;35(suppl):abstr 5519.
4.
5.
6.
Ledermann JA, et al. J Clin Oncol. 2017;35(suppl):abstr 5518.
7.
Friedlander M, et al. J Clin Oncol. 2017;35(suppl):abstr 5507.
8.
Mansoor Raza M, et al. J Clin Oncol. 2017;35(suppl):abstr 5517.
9.
Ledermann JA, et al. J Clin Oncol. 2017;35(suppl):abstr 5506.
10.
Knipprath-Meszaros A, et al. J Clin Oncol. 2017;35(suppl):abstr 5515.
11.
de Boer SM, et al. J Clin Oncol. 2017;35(suppl):abstr 5502.
12.
Matei D, et al. J Clin Oncol. 2017;35(suppl):abstr 5505.
13.
Hollebecque A, et al. J Clin Oncol. 2017;35(suppl):abstr 5504.
Metadata
Title
ASCO 2017—highlights of gynecological cancer
Authors
Bianca Radl
Brigitte Mlineritsch
Publication date
01-12-2017
Publisher
Springer Vienna
Published in
memo - Magazine of European Medical Oncology / Issue 4/2017
Print ISSN: 1865-5041
Electronic ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-017-0371-z

Other articles of this Issue 4/2017

memo - Magazine of European Medical Oncology 4/2017 Go to the issue

short review

ASCO update: lung cancer

short review

Antiangiogenic therapies in colorectal cancer

review

ASCO 2017: highlights in breast cancer

short review

Next generation sequencing: clinical applications in solid tumours

short review

Anti-angiogenic therapies for the treatment of angiosarcoma: a clinical update

short review

Update on squamous cell carcinoma of the head and neck
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits